FDA faces furloughs if Senate misses August deadline for user fee bill

House Energy and Commerce Leaders warned that time is running short for the Senate to pass its version of the Food and Drug Administration user fee amendments, which set the agency’s ability to collect fees from medical device and biopharma companies to fund its review of products.